Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Spectrum Pharmaceuticals, Inc.    SPPI   US84763A1088

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
7.99(c) 8.15(c) 8.11(c) 7.97(c) 8.11(c) Last
957 069 1 217 290 573 690 672 455 455 522 Volume
+1.01% +2.00% -0.49% -1.73% +1.76% Change
More quotes
Company
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations, with a primary focus in hematology and oncology. It operates through one segment: acquiring, developing and commercializing prescription drug products. The company markets two... 
Surperformance© rating of Spectrum Pharmaceuticals,
Trading Rating : Investor Rating :
More about the company
Chart SPECTRUM PHARMACEUTICALS,
Duration : Period :
Spectrum Pharmaceuticals,  Technical Analysis Chart | SPPI | US84763A1088 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 179 M
EBIT 2014 -39,9 M
Net income 2014 -47,7 M
Debt 2014 -
Yield 2014 -
Sales 2015 207 M
EBIT 2015 3,02 M
Net income 2015 -2,78 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 2,98x
Capi. / Sales 2015 2,58x
Capitalization 533 M
More Financials
Latest news on SPECTRUM PHARMACEUTICALS,
4d ago SPECTRUM PHARMACEUTICALS : Assigned Patent
5d ago SPECTRUM PHARMACEUTICALS : SPPI) Jumps 5.33% on August 22
08/25 SPECTRUM PHARMACEUTICALS : Momentum Indicators for Biotech Stocks -- Exact Scien..
08/22 SPECTRUM PHARMACEUTICALS : Determination That FUSILEV (Levoleucovorin Calcium), ..
08/16 SPECTRUM PHARMACEUTICALS : Reports Second Quarter Earnings
08/13 SPECTRUM PHARMACEUTICALS : Reports 45% Sales Growth in the Second Quarter, Launc..
08/12 SPECTRUM PHARMACEUTICALS : Posts Second Quarter Earnings
08/08 SPECTRUM PHARMACEUTICALS : Reports 45% Sales Growth in the Second Quarter, Launc..
08/07 SPECTRUM PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
08/07 SPECTRUM PHARMACEUTICALS : Reports 45% Sales Growth in the Second Quarter, Launc..
07/31 SPECTRUM PHARMACEUTICALS : Announces Second Quarter 2014 Financial Results Telec..
07/09 BIOALLIANCE PHARMA : FDA approval of Beleodaq™ belinostat
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
Spectrum Pharmaceuticals,  : Income Statement Evolution
More Financials
EPS Revisions
Spectrum Pharmaceuticals,  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF